Suppr超能文献

微小RNA与癌症;综述

MicroRNAs and cancer; an overview.

作者信息

Tutar Lutfi, Tutar Esen, Tutar Yusuf

机构信息

Department of Biochemistry, Faculty of Pharmacy, Cumhuriyet University, Sivas, Turkey, 58140.

出版信息

Curr Pharm Biotechnol. 2014;15(5):430-7. doi: 10.2174/1389201015666140519095304.

Abstract

MiRNAs are a family of small, endogenous, and evolutionarily conserved non-coding ribonucleic acids that have been involved in the regulation of several essential, cellular, and functional processes. MicroRNAs are known to play key roles in all types of cancer and function as oncogenes (oncomirs) or tumour-suppressors in up-regulation or down-regulation processes respectively. MiRNAs have potential power to be examined as prognostic and diagnostic biomarkers. Modulating miRNAs, based on two major approaches (miRNA mimics and miRNA antagonists), is used for clinical development of therapeutic miRNAs. This review emphasizes the latest discovery in the field of miRNA research involved in cancer, biomarkers, and therapeutics.

摘要

微小RNA(miRNA)是一类小型的、内源性的且在进化上保守的非编码核糖核酸,它们参与了多种重要的细胞和功能过程的调控。已知微小RNA在所有类型的癌症中都发挥着关键作用,分别在上调或下调过程中作为癌基因(致癌miRNA)或肿瘤抑制因子发挥作用。微小RNA有潜力作为预后和诊断生物标志物进行检测。基于两种主要方法(miRNA模拟物和miRNA拮抗剂)对微小RNA进行调控,用于治疗性微小RNA的临床开发。本综述着重介绍了微小RNA研究领域在癌症、生物标志物和治疗方面的最新发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验